Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Lin

Showing results (131-140 of 328) with videos related to

Pageof 33
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung CancerYifan Wang, Nan Li, Wen Jiang, et al.
Journal of Gastrointestinal Oncology|February 3, 2015
A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancerSteven H Lin, Jingya Wang, Pamela K Allen, et al.
Clinical Lung Cancer|August 17, 2020
Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in Non-Small-Cell Lung Cancer Treated With Chemoradiation and AtezolizumabAlexander Augustyn, Daniel L Adams, Jianzhong He, et al.
Scientific Reports|November 22, 2019
Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndromeBhanu Prasad Venkatesulu, Amrish Sharma, Julianne M Pollard-Larkin, et al.
Annals of Surgical Oncology|December 25, 2012
Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgeryArya Amini, Feiran Lou, Arlene M Correa, et al.
Journal of Gastrointestinal Oncology|January 4, 2019
Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapyRanda Tao, Bryan Ager, Shane Lloyd, et al.
Practical Radiation Oncology|August 26, 2019
Commercial Insurance Coverage of Advanced Radiation Therapy Techniques Compared With American Society for Radiation Oncology Model PoliciesVivek Verma, Ethan B Ludmir, Shane M Mesko, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2016
The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal CancerPeter S N van Rossum, David V Fried, Lifei Zhang, et al.
Scientific Reports|July 1, 2020
Author Correction: Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndromeBhanu Prasad Venkatesulu, Amrish Sharma, Julianne M Pollard-Larkin, et al.
Acta Oncologica (Stockholm, Sweden)|December 16, 2021
Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancerWaqar Haque, Anukriti Singh, Henry S Park, et al.
Pageof 33

Showing results (131-140 of 328) with videos related to

Sort By:
Pageof 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung CancerYifan Wang, Nan Li, Wen Jiang, et al.
Journal of Gastrointestinal Oncology|February 3, 2015
A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancerSteven H Lin, Jingya Wang, Pamela K Allen, et al.
Clinical Lung Cancer|August 17, 2020
Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in Non-Small-Cell Lung Cancer Treated With Chemoradiation and AtezolizumabAlexander Augustyn, Daniel L Adams, Jianzhong He, et al.
Scientific Reports|November 22, 2019
Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndromeBhanu Prasad Venkatesulu, Amrish Sharma, Julianne M Pollard-Larkin, et al.
Annals of Surgical Oncology|December 25, 2012
Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgeryArya Amini, Feiran Lou, Arlene M Correa, et al.
Journal of Gastrointestinal Oncology|January 4, 2019
Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapyRanda Tao, Bryan Ager, Shane Lloyd, et al.
Practical Radiation Oncology|August 26, 2019
Commercial Insurance Coverage of Advanced Radiation Therapy Techniques Compared With American Society for Radiation Oncology Model PoliciesVivek Verma, Ethan B Ludmir, Shane M Mesko, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2016
The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal CancerPeter S N van Rossum, David V Fried, Lifei Zhang, et al.
Scientific Reports|July 1, 2020
Author Correction: Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndromeBhanu Prasad Venkatesulu, Amrish Sharma, Julianne M Pollard-Larkin, et al.
Acta Oncologica (Stockholm, Sweden)|December 16, 2021
Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancerWaqar Haque, Anukriti Singh, Henry S Park, et al.
Pageof 33